Skip to content

88339KAA0THERAVANCE BIOPHARMA INC

CUSIP 88339KAA0 · debt

No tracked investor reported shares of THERAVANCE BIOPHARMA INC (88339KAA0) for Q3 2022. Seth Klarman sold out of its position this quarter.

Holders · Q3 2022
0
New holders
0
Value held
$0
Quarter-end price (est.)
—

Investors holding 88339KAA0 · Q3 2022

No tracked investor reported shares this quarter.

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
Seth Klarman0.38%28,104,000$25.9MEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2022001$0—
Q2 2022100$25.9M$0.92
Q1 2022100$28.6M$0.95
Q4 2021100$28.8M$0.96
Q3 2021100$27.6M$0.92
Q2 2021100$28.6M$0.95
Q1 2021100$30.6M$1.02
Q4 2020100$28.4M$0.95
Q3 2020100$26.3M$0.88
Q2 2020100$29.2M$0.97
Q1 2020100$28.7M$0.96
Q4 2019100$31.1M$1.04
Q3 2019100$27.7M$0.92
Q2 2019100$25.7M$0.86
Q1 2019100$29.2M$0.97
Q4 2018100$30.9M$1.03
Q3 2018100$34.6M$1.15
Q2 2018100$30M$1.00
Q1 2018100$30.2M$1.01
Q4 2017100$33M$1.10
Q3 2017100$37.1M$1.24
Q2 2017100$40.4M$1.35
Q1 2017100$37.8M$1.26
Q4 2016110$34.1M$1.14